Therapeutic tumor vaccines-a rising star to benefit cancer patients

Malignant tumors are still a worldwide threat to human health.Tumor treatment strategies are constantly evolving,and the advent of tumor immunotherapy has brought up hope to many types of tumors,especially for those that are refractory to conventional therapies including surgery,radiotherapy,and chemotherapy.Tumor vaccines can initiate or amplify an anti-tumor immune response in tumor patients through active immunization,and therefore occupy an important position in tumor immunotherapy.The main types of tumor vaccines include tumor cell vaccines,dendritic cell vaccines,polypeptide vaccines and nucleic acid vaccines.Due to factors such as poor antigen selection and suppressive tumor microenvironment,earliest tumor vaccines on clinical trials failed to achieve satisfactory clinical effects.However,with the development of second-generation genome sequencing technologies and bioinformatics tools,it is possible to predict neoantigens generated by tumor-specific mutations and therefore prepare personalized vaccines.This article summarizes the global efforts in developing tumor vaccines and highlights several representative tumor vaccines in each category.

Effective electrocatalytic hydrodechlorination of 2,4,6-trichlorophenol by a novel Pd/MnO_(2)/Ni foam cathode

Pd modified electrodes possess problems such as easy agglomeration and low electrolytic ability,and the use of manganese dioxide(MnO_(2)) to facilitate Pd reduction of organic pollutants is just started.However,there is still a limited understanding of how to match the Pd load and MnO_(2) to realize optimal dechlorination efficiency at minimum cost.Here,a Pd/MnO_(2)/Ni foam cathode was successfully fabricated and applied for the efficient electrochemical dechlorination of 2,4,6-trichlorophenol(2,4,6-TCP).The optimal electrocatalytic hydrodechlorination(ECH)performance with 2,4,6-TCP dechlorination efficiency(92.58%in 180 min)was obtained when the concentration of PdCl_(2) precipitation was 1 mmol/L,the deposition time of MnO_(2) was 300 s and cathode potential was-0.8 V.Performance influenced by the exogenous factors(e.g.,initial pH and coexisted ions)were further investigated.It was found that the neutral pH was the most favorable for ECH and a reduction in dechlorination efficiency(6%~47.6%)was observed in presence of 5 mmol/L of NO_(2)^(-),NO_(3)^(-),S^(2-)or SO_(3)^(2-).Cyclic voltammetry(CV)and quenching experiments verified the existence of three hydrogen species on Pd surface,including adsorbed atomic hydrogen(H^(*)_(ads)),absorbed atomic hydrogen(H^(*)_(abs)),and molecular hydrogen(H_(2)).And the introduction of MnO_(2)promoted the generation of atomic H^(*).Only adsorbed atomic hydrogen(H^(*)_(ads)) was confirmed that it truly facilitated the ECH process.Besides H^(*)_(ads) induced reduction,the direct reduction by cathode electrons also participated in the 2,4,6-TCP dechlorination process.Pd/MnO_(2)/Ni foam cathode shows excellent dechlorination performance,fine stability and recyclable potential,which provides strategies for the effective degradation of persistent halogenated organic pollutants in groundwater.